Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modelling of formic acid production using solventless trialkylamine reduction strategies.

Physical chemistry chemical physics : PCCP·2025
Same author

Risk of Congenital Ocular Anomaly After Prenatal Exposure to Medications: A EUROmediCAT Study.

Birth defects research·2025
Same author

Impact of therapeutic education on the evolution of social representations of medication in patients with Parkinson's disease: A quantitative and qualitative study (ETPARK REMED).

Revue neurologique·2023
Same author

Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.

Vaccine·2021
Same author

Kangaroo mother care can improve the short-term outcomes of very preterm infants.

Journal of neonatal-perinatal medicine·2020
Same author

Recommendation for hygiene and topical in neonatology from the French Neonatal Society.

European journal of pediatrics·2019

Related Experiment Video

Updated: Jul 10, 2026

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
09:11

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

[Necrotizing enterocolitis in a full-term infant. Is acyclovir involved?].

N Montjaux-Régis1, A Chanot, P Olivier

  • 1Unité de néonatologie, hôpital des Enfants, 330, avenue de Grande-Bretagne, 31059 Toulouse cedex 09, France. montjaux.n@chu-toulouse.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|October 16, 2007
PubMed
Summary

Acyclovir, used to treat herpes, may pose risks to newborns. This case suggests a potential link between acyclovir prophylaxis and necrotizing enterocolitis in infants, warranting careful consideration of its use.

More Related Videos

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome
06:51

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome

Published on: July 28, 2023

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

Related Experiment Videos

Last Updated: Jul 10, 2026

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
09:11

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome
06:51

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome

Published on: July 28, 2023

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Virology

Background:

  • Acyclovir is a widely used antiviral medication effective against herpes simplex virus infections.
  • Antiviral exposure during pregnancy and the neonatal period is generally considered safe.
  • Herpes simplex virus infections in pregnant individuals require careful management to prevent transmission to the neonate.

Observation:

  • A case of a full-term infant developing early-stage necrotizing enterocolitis is presented.
  • The infant received acyclovir prophylactically following in utero and postnatal exposure.
  • Maternal herpes genitalis and premature rupture of membranes were noted during pregnancy.

Findings:

  • The study explores acyclovir treatment in utero and postnatally as a potential contributing factor to necrotizing enterocolitis.
  • Necrotizing enterocolitis is a serious gastrointestinal condition affecting premature and newborn infants.
  • The safety profile of acyclovir in neonates requires further investigation in specific contexts.

Implications:

  • Acyclovir use in neonates, particularly for prophylaxis, should be carefully weighed against potential risks.
  • Further research is needed to elucidate the relationship between acyclovir and necrotizing enterocolitis.
  • Clinical guidelines may need revision regarding prophylactic acyclovir use in high-risk neonates.